<VariationArchive VariationID="2506987" VariationName="NM_000203.5(IDUA):c.34_46del (p.Ala12fs)" VariationType="Deletion" Accession="VCV002506987" Version="1" RecordType="classified" NumberOfSubmissions="1" NumberOfSubmitters="1" DateLastUpdated="2024-07-29" DateCreated="2023-07-01" MostRecentSubmission="2023-07-01">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="2671968" VariationID="2506987">
      <GeneList>
        <Gene Symbol="IDUA" FullName="alpha-L-iduronidase" GeneID="3425" HGNC_ID="HGNC:5391" Source="submitted" RelationshipType="within multiple genes by overlap">
          <Location>
            <CytogeneticLocation>4p16.3</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="4" Accession="NC_000004.12" start="986997" stop="1008351" display_start="986997" display_stop="1008351" Strand="+" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="4" Accession="NC_000004.11" start="980784" stop="998316" display_start="980784" display_stop="998316" Strand="+" />
          </Location>
          <OMIM>252800</OMIM>
        </Gene>
        <Gene Symbol="SLC26A1" FullName="solute carrier family 26 member 1" GeneID="10861" HGNC_ID="HGNC:10993" Source="calculated" RelationshipType="within multiple genes by overlap">
          <Location>
            <CytogeneticLocation>4p16.3</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="4" Accession="NC_000004.12" start="978991" stop="993404" display_start="978991" display_stop="993404" Strand="-" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="4" Accession="NC_000004.11" start="972860" stop="987223" display_start="972860" display_stop="987223" Strand="-" />
          </Location>
          <OMIM>610130</OMIM>
        </Gene>
      </GeneList>
      <Name>NM_000203.5(IDUA):c.34_46del (p.Ala12fs)</Name>
      <CanonicalSPDI>NC_000004.12:987117:GCGCTCCTGGCCT:</CanonicalSPDI>
      <VariantType>Deletion</VariantType>
      <Location>
        <CytogeneticLocation>4p16.3</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="4" Accession="NC_000004.12" start="987118" stop="987130" display_start="987118" display_stop="987130" variantLength="13" positionVCF="987117" referenceAlleleVCF="GGCGCTCCTGGCCT" alternateAlleleVCF="G" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="4" Accession="NC_000004.11" start="980906" stop="980918" display_start="980906" display_stop="980918" variantLength="13" positionVCF="980905" referenceAlleleVCF="GGCGCTCCTGGCCT" alternateAlleleVCF="G" />
      </Location>
      <OtherNameList>
        <Name>p.Ala12ArgfsTer92</Name>
      </OtherNameList>
      <ProteinChange>A12fs</ProteinChange>
      <HGVSlist>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000004.11" sequenceAccession="NC_000004" sequenceVersion="11" change="g.980906_980918del" Assembly="GRCh37">
            <Expression>NC_000004.11:g.980906_980918del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000004.12" sequenceAccession="NC_000004" sequenceVersion="12" change="g.987118_987130del" Assembly="GRCh38">
            <Expression>NC_000004.12:g.987118_987130del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_008103.1" sequenceAccession="NG_008103" sequenceVersion="1" change="g.5122_5134del">
            <Expression>NG_008103.1:g.5122_5134del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_033042.1" sequenceAccession="NG_033042" sequenceVersion="1" change="g.11307_11319del">
            <Expression>NG_033042.1:g.11307_11319del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_158244.2" sequenceAccession="NG_158244" sequenceVersion="2" change="g.318_330del">
            <Expression>NG_158244.2:g.318_330del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_000203.5" sequenceAccession="NM_000203" sequenceVersion="5" change="c.34_46del" MANESelect="true">
            <Expression>NM_000203.5:c.34_46del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_000194.2" sequenceAccession="NP_000194" sequenceVersion="2" change="p.Ala12fs">
            <Expression>NP_000194.2:p.Ala12fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="non-coding">
          <NucleotideExpression sequenceAccessionVersion="NR_110313.1" sequenceAccession="NR_110313" sequenceVersion="1" change="n.122_134del">
            <Expression>NR_110313.1:n.122_134del</Expression>
          </NucleotideExpression>
          <MolecularConsequence ID="SO:0001619" Type="non-coding transcript variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_134425.4" sequenceAccession="NM_134425" sequenceVersion="4" change="c.576+3998_576+4010del">
            <Expression>NM_134425.4:c.576+3998_576+4010del</Expression>
          </NucleotideExpression>
          <MolecularConsequence ID="SO:0001627" Type="intron variant" DB="SO" />
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="LRG_1277" sequenceAccession="LRG_1277">
            <Expression>LRG_1277:g.5122_5134del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="LRG_1277t1" sequenceAccession="LRG_1277t1">
            <Expression>LRG_1277t1:c.34_46del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="LRG_1277p1" sequenceAccession="LRG_1277p1" change="p.Ala12fs">
            <Expression>LRG_1277p1:p.Ala12fs</Expression>
          </ProteinExpression>
        </HGVS>
      </HGVSlist>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_000203.5(IDUA):c.34_46del (p.Ala12fs) AND Mucopolysaccharidosis, MPS-I-S" Accession="RCV003237393" Version="8">
        <ClassifiedConditionList TraitSetID="3231">
          <ClassifiedCondition DB="MedGen" ID="C0026708">Mucopolysaccharidosis, MPS-I-S</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2023-06-24" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2023-06-24" NumberOfSubmissions="1" NumberOfSubmitters="1" DateCreated="2023-07-01" MostRecentSubmission="2023-07-01">
        <ReviewStatus>criteria provided, single submitter</ReviewStatus>
        <Description>Pathogenic</Description>
        <ConditionList>
          <TraitSet ID="3231" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="3695" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">MUCOPOLYSACCHARIDOSIS TYPE IS</ElementValue>
                <XRef Type="MIM" ID="607016" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">MPS V</ElementValue>
                <XRef Type="MIM" ID="607016" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">MUCOPOLYSACCHARIDOSIS TYPE V</ElementValue>
                <XRef Type="MIM" ID="607016" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Scheie Syndrome</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Preferred">Mucopolysaccharidosis, MPS-I-S</ElementValue>
                <XRef ID="Mucopolysaccharidosis%2C+MPS-I-S/8912" DB="Genetic Alliance" />
                <XRef ID="73123008" DB="SNOMED CT" />
              </Name>
              <Symbol>
                <ElementValue Type="Alternate">MPS1-S</ElementValue>
                <XRef Type="MIM" ID="607016" DB="OMIM" />
              </Symbol>
              <Symbol>
                <ElementValue Type="Alternate">MPS5</ElementValue>
                <XRef Type="MIM" ID="607016" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="public definition">Mucopolysaccharidosis type I (MPS I) is a progressive multisystem disorder with features ranging over a continuum of severity. While affected individuals have traditionally been classified as having one of three MPS I syndromes (Hurler syndrome, Hurler-Scheie syndrome, or Scheie syndrome), no easily measurable biochemical differences have been identified and the clinical findings overlap. Affected individuals are best described as having either a phenotype consistent with either severe (Hurler syndrome) or attenuated MPS I, a distinction that influences therapeutic options. Severe MPS I. Infants appear normal at birth. Typical early manifestations are nonspecific (e.g., umbilical or inguinal hernia, frequent upper respiratory tract infections before age 1 year). Coarsening of the facial features may not become apparent until after age one year. Gibbus deformity of the lower spine is common and often noted within the first year. Progressive skeletal dysplasia (dysostosis multiplex) involving all bones is universal, as is progressive arthropathy involving most joints. By age three years, linear growth decreases. Intellectual disability is progressive and profound but may not be readily apparent in the first year of life. Progressive cardiorespiratory involvement, hearing loss, and corneal clouding are common. Without treatment, death (typically from cardiorespiratory failure) usually occurs within the first ten years of life. Attenuated MPS I. Clinical onset is usually between ages three and ten years. The severity and rate of disease progression range from serious life-threatening complications leading to death in the second to third decade, to a normal life span complicated by significant disability from progressive joint manifestations and cardiorespiratory disease. While some individuals have no neurologic involvement and psychomotor development may be normal in early childhood, learning disabilities and psychiatric manifestations can be present later in life. Hearing loss, cardiac valvular disease, respiratory involvement, and corneal clouding are common.</Attribute>
                <XRef ID="NBK1162" DB="GeneReviews" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="12561" />
                <XRef ID="12561" DB="Office of Rare Diseases" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301341</ID>
                <ID Source="BookShelf">NBK1162</ID>
              </Citation>
              <Citation Type="practice guideline" Abbrev="ACMG ACT, 2023">
                <URL>https://www.acmg.net/PDFLibrary/MPSI-ACT-Sheet.pdf</URL>
                <CitationText>American College of Medical Genetics and Genomics, Newborn Screening ACT Sheet, alpha-L-iduronidase deficiency with or without glycosaminoglycan (GAG) accumulation, Mucopolysaccharidosis Type 1 (MPS I), 2023</CitationText>
              </Citation>
              <Citation Type="practice guideline" Abbrev="ACMG Algorithm, 2023">
                <URL>https://www.acmg.net/PDFLibrary/MPSI-Algorithm.pdf</URL>
                <CitationText>ACMG Algorithm, MPS I: Decreased Alpha-L-Iduronidase; Elevated Dermatan and Heparan Sulfates, 2023</CitationText>
              </Citation>
              <XRef ID="93474" DB="Orphanet" />
              <XRef ID="C0026708" DB="MedGen" />
              <XRef ID="MONDO:0011760" DB="MONDO" />
              <XRef Type="MIM" ID="607016" DB="OMIM" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="7358257" SubmissionDate="2023-06-30" DateLastUpdated="2023-07-01" DateCreated="2023-07-01">
        <ClinVarSubmissionID localKey="SUB13586478" submittedAssembly="GRCh37" title="SUB13586478" />
        <ClinVarAccession Accession="SCV003936003" DateUpdated="2023-07-01" DateCreated="2023-07-01" Type="SCV" Version="1" SubmitterName="Foundation for Research in Genetics and Endocrinology, FRIGE's Institute of Human Genetics" OrgID="505565" OrganizationCategory="other" OrgAbbreviation="FRIGE - IHG" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2023-06-24">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Comment>A homozygous twelve base pair deletion in exon 1 of the IDUA gene that results in a frameshift and premature truncation of the protein 92 amino acids downstream to codon 12 (p.Ala12ArgfsTer92) was detected . This variant has not been reported in the 1000 genomes and gnomAD databases. The in-silico prediction of the variant is disease causing by MutationTaster2. In summary, the variant meets our criteria to be classified as pathogenic.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="ModeOfInheritance">Autosomal recessive inheritance</Attribute>
        </AttributeSet>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <Age Type="minimum" age_unit="years">0</Age>
              <Age Type="maximum" age_unit="years">9</Age>
              <AffectedStatus>yes</AffectedStatus>
              <Gender>female</Gender>
            </Sample>
            <Method>
              <NamePlatform>Illumina sequencing platform</NamePlatform>
              <TypePlatform>Next-generation sequencing</TypePlatform>
              <Description>DNA extracted from blood was used to perform targeted gene capture using a custom smMIP panel. The libraries were sequenced to mean &gt;100-300X coverage on the Illumina MiSeq sequencing platform. The sequences obtained are aligned to the human reference genome (GRCh37) using the BWA program and analyzed using Picard and GATK version 4.1.2 to identify variants relevant to the clinical indication.</Description>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Homozygote" integerValue="1" />
            </ObservedData>
            <TraitSet DateLastEvaluated="2023-06-01" Type="Finding">
              <Trait ClinicalFeaturesAffectedStatus="present" Type="Finding">
                <XRef DB="HP" ID="HP:0000280" />
              </Trait>
              <Trait ClinicalFeaturesAffectedStatus="present" Type="Finding">
                <XRef DB="HP" ID="HP:0002240" />
              </Trait>
              <Trait ClinicalFeaturesAffectedStatus="present" Type="Finding">
                <XRef DB="HP" ID="HP:0001028" />
              </Trait>
            </TraitSet>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="IDUA">
              <Name>alpha-L-iduronidase</Name>
            </Gene>
          </GeneList>
          <VariantType>Variation</VariantType>
          <Location>
            <GeneLocation>NM_000203.5:exon 1</GeneLocation>
          </Location>
          <OtherNameList>
            <Name Type="SubmitterVariantId">S-106</Name>
            <Name>p.Ala12ArgfsTer92</Name>
          </OtherNameList>
          <AttributeSet>
            <Attribute Type="HGVS">NM_000203.5:c.34_46del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="607016" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB13586478</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="7358257" TraitType="Disease" MappingType="XRef" MappingValue="607016" MappingRef="OMIM">
        <MedGen CUI="C0026708" Name="Mucopolysaccharidosis, MPS-I-S" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="7358257" TraitType="Finding" MappingType="XRef" MappingValue="HP:0001028" MappingRef="HP">
        <MedGen CUI="C0018916" Name="Hemangioma" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="7358257" TraitType="Finding" MappingType="XRef" MappingValue="HP:0002240" MappingRef="HP">
        <MedGen CUI="C0019209" Name="Hepatomegaly" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="7358257" TraitType="Finding" MappingType="XRef" MappingValue="HP:0000280" MappingRef="HP">
        <MedGen CUI="C1845847" Name="Coarse facial features" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

